Literature DB >> 21775174

Under HEMA conditions, self-replication of human erythroblasts is limited by autophagic death.

Giovanni Migliaccio1, Francesca Masiello, Valentina Tirelli, Massimo Sanchez, Lilian Varricchio, Carolyn Whitsett, Anna Rita Migliaccio.   

Abstract

The number of erythroblasts generated ex-vivo under human-erythroid massive-amplification conditions by mononuclear cells from one unit of adult blood (~10(10)) are insufficient for transfusion (~10(12) red cells), emphasizing the need for studies to characterize cellular interactions during culture to increase erythroblast production. To identify the cell populations which generate erythroblasts under human-erythroid-massive-amplification conditions and the factors that limit proliferation, day 10 non-erythroblasts and immature- and mature-erythroblasts were separated by sorting, labelled with carboxyfluorescein-diacetate-succinimidyl-ester and re-cultured either under these conditions (for proliferation, maturation and/or apoptosis/autophagy determinations) or in semisolid media (for progenitor cell determination). Non-erythroblasts contained 54% of the progenitor cells but did not grow under human-erythroid-massive-amplification conditions. Immature-erythroblasts contained 25% of the progenitor cells and generated erythroblasts under human-erythroid-massive-amplification conditions (FI at 48 h=2.57±1.15). Mature-erythroblasts did not generate colonies and died in human-erythroid-massive-amplification conditions. In sequential sorting/re-culture experiments, immature-erythroblasts retained the ability to generate erythroblasts for 6 days and generated 2-5-fold more cells than the corresponding unfractionated population, suggesting that mature-erythroblasts may limit erythroblast expansion. In co-cultures of carboxyfluorescein-diacetate-succinimidyl-ester-labelled-immature-erythroblasts with mature-erythroblasts at increasing ratios, cell numbers did not increase and proliferation, maturation and apoptotic rates were unchanged. However, Acridine Orange staining (a marker for autophagic death) increased from ~3.2% in cultures with immature-erythroblasts alone to 14-22% in cultures of mature-erythroblasts with and without immature-erythroblasts. In conclusion, these data identify immature-erythroblasts as the cells that generate additional erythroblasts in human-erythroid-massive-amplification cultures and autophagy as the leading cause of death limiting the final cellular output of these cultures.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21775174     DOI: 10.1016/j.bcmd.2011.06.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  16 in total

Review 1.  Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusion.

Authors:  Ann Zeuner; Fabrizio Martelli; Stefania Vaglio; Giulia Federici; Carolyn Whitsett; Anna Rita Migliaccio
Journal:  Stem Cells       Date:  2012-08       Impact factor: 6.277

2.  The expression of the glucocorticoid receptor in human erythroblasts is uniquely regulated by KIT ligand: implications for stress erythropoiesis.

Authors:  Lilian Varricchio; Valentina Tirelli; Elena Masselli; Barbara Ghinassi; Nayanendu Saha; Peter Besmer; Anna Rita Migliaccio
Journal:  Stem Cells Dev       Date:  2012-07-09       Impact factor: 3.272

Review 3.  Concise review: production of cultured red blood cells from stem cells.

Authors:  Eric E Bouhassira
Journal:  Stem Cells Transl Med       Date:  2012-11-26       Impact factor: 6.940

Review 4.  Concise Review: Advanced Cell Culture Models for Diamond Blackfan Anemia and Other Erythroid Disorders.

Authors:  Anna Rita Migliaccio; Lilian Varricchio
Journal:  Stem Cells       Date:  2017-12-05       Impact factor: 6.277

5.  Blood in a dish: In vitro synthesis of red blood cells.

Authors:  Anna Rita Migliaccio; James Palis
Journal:  Drug Discov Today Dis Mech       Date:  2011

6.  Preclinical rationale for TGF-β inhibition as a therapeutic target for the treatment of myelofibrosis.

Authors:  Ilaria Ceglia; Amylou C Dueck; Francesca Masiello; Fabrizio Martelli; Wu He; Giulia Federici; Emanuel F Petricoin; Ann Zeuner; Camelia Iancu-Rubin; Rona Weinberg; Ronald Hoffman; John Mascarenhas; Anna Rita Migliaccio
Journal:  Exp Hematol       Date:  2016-08-31       Impact factor: 3.084

7.  Dexamethasone targeted directly to macrophages induces macrophage niches that promote erythroid expansion.

Authors:  Mario Falchi; Lilian Varricchio; Fabrizio Martelli; Francesca Masiello; Giulia Federici; Maria Zingariello; Gabriella Girelli; Carolyn Whitsett; Emanuel F Petricoin; Søren Kragh Moestrup; Ann Zeuner; Anna Rita Migliaccio
Journal:  Haematologica       Date:  2014-12-22       Impact factor: 9.941

Review 8.  Ex-vivo expansion of red blood cells: how real for transfusion in humans?

Authors:  Anna Rita Migliaccio; Elena Masselli; Lilian Varricchio; Carolyn Whitsett
Journal:  Blood Rev       Date:  2011-12-15       Impact factor: 8.250

9.  The role of glucocorticoid receptor (GR) polymorphisms in human erythropoiesis.

Authors:  Lilian Varricchio; Anna Rita Migliaccio
Journal:  Am J Blood Res       Date:  2014-12-15

10.  Transcriptomic and phospho-proteomic analyzes of erythroblasts expanded in vitro from normal donors and from patients with polycythemia vera.

Authors:  Todd Hricik; Giulia Federici; Ann Zeuner; Giuliana Alimena; Agostino Tafuri; Valentina Tirelli; Lilian Varricchio; Francesca Masiello; Fiorella Ciaffoni; Stefania Vaglio; Emanuel F Petricoin; Gabriella Girelli; Ross L Levine; Anna Rita F Migliaccio
Journal:  Am J Hematol       Date:  2013-07-03       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.